142 related articles for article (PubMed ID: 9699891)
1. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
Humphries SE; Luong LA; Talmud PJ; Frick MH; Kesäniemi YA; Pasternack A; Taskinen MR; Syvänne M
Atherosclerosis; 1998 Jul; 139(1):49-56. PubMed ID: 9699891
[TBL] [Abstract][Full Text] [Related]
2. Interaction between smoking and the stromelysin-1 (MMP3) gene 5A/6A promoter polymorphism and risk of coronary heart disease in healthy men.
Humphries SE; Martin S; Cooper J; Miller G
Ann Hum Genet; 2002 Nov; 66(Pt 5-6):343-52. PubMed ID: 12485468
[TBL] [Abstract][Full Text] [Related]
3. The stromelysin-1 5A/6A promoter polymorphism is a disease marker for the extent of coronary heart disease.
Schwarz A; Haberbosch W; Tillmanns H; Gardemann A
Dis Markers; 2002; 18(3):121-8. PubMed ID: 12515907
[TBL] [Abstract][Full Text] [Related]
4. 5A/6A polymorphism of the stromelysin-1 gene and angiographic restenosis after coronary artery stenting.
Chiou KR; Chung SL; Charng MJ
J Chin Med Assoc; 2005 Nov; 68(11):506-12. PubMed ID: 16323393
[TBL] [Abstract][Full Text] [Related]
5. A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
Syvänne M; Taskinen MR; Nieminen ; Manninen V; Kesäniemi YA; Pasternack A; Nawrocki JW; Haber H; Frick MH
Control Clin Trials; 1997 Feb; 18(1):93-119. PubMed ID: 9055055
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
Ye S; Watts GF; Mandalia S; Humphries SE; Henney AM
Br Heart J; 1995 Mar; 73(3):209-15. PubMed ID: 7727178
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
Frick MH; Syvänne M; Nieminen MS; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Taskinen MR
Circulation; 1997 Oct; 96(7):2137-43. PubMed ID: 9337181
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
Liu PY; Chen JH; Li YH; Wu HL; Shi GY
Thromb Haemost; 2003 Jul; 90(1):132-9. PubMed ID: 12876636
[TBL] [Abstract][Full Text] [Related]
9. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis.
de Maat MP; Jukema JW; Ye S; Zwinderman AH; Moghaddam PH; Beekman M; Kastelein JJ; van Boven AJ; Bruschke AV; Humphries SE; Kluft C; Henney AM
Am J Cardiol; 1999 Mar; 83(6):852-6. PubMed ID: 10190398
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
Gnasso A; Motti C; Irace C; Carallo C; Liberatoscioli L; Bernardini S; Massoud R; Mattioli PL; Federici G; Cortese C
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1600-5. PubMed ID: 10845878
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Liu PY; Li YH; Chan SH; Lin LJ; Wu HL; Shi GY; Chen JH
Am J Cardiol; 2006 Oct; 98(8):1012-7. PubMed ID: 17027562
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
Terashima M; Akita H; Kanazawa K; Inoue N; Yamada S; Ito K; Matsuda Y; Takai E; Iwai C; Kurogane H; Yoshida Y; Yokoyama M
Circulation; 1999 Jun; 99(21):2717-9. PubMed ID: 10351963
[TBL] [Abstract][Full Text] [Related]
13. [Association between single nucleotide polymorphisms of matrix metalloproteinase-3 gene and the severity of coronary atherosclerosis in patients with coronary artery disease].
Wu NQ; Song L; Hua YH; Lu XF; Ye J; Li JX; Gu DF; Yang YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):501-5. PubMed ID: 19100060
[TBL] [Abstract][Full Text] [Related]
14. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene.
Takahashi M; Haro H; Wakabayashi Y; Kawa-uchi T; Komori H; Shinomiya K
J Bone Joint Surg Br; 2001 May; 83(4):491-5. PubMed ID: 11380116
[TBL] [Abstract][Full Text] [Related]
15. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
Hoppmann P; Koch W; Schömig A; Kastrati A
Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
[TBL] [Abstract][Full Text] [Related]
16. Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population.
Beilby JP; Chapman CM; Palmer LJ; McQuillan BM; Thompson PL; Hung J
J Hypertens; 2005 Mar; 23(3):537-42. PubMed ID: 15716694
[TBL] [Abstract][Full Text] [Related]
17. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Samnegård A; Silveira A; Lundman P; Boquist S; Odeberg J; Hulthe J; McPheat W; Tornvall P; Bergstrand L; Ericsson CG; Hamsten A; Eriksson P
J Intern Med; 2005 Nov; 258(5):411-9. PubMed ID: 16238676
[TBL] [Abstract][Full Text] [Related]
18. Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy.
Gantala SR; Kondapalli MS; Kummari R; Padala C; Tupurani MA; Kupsal K; Galimudi RK; Gundapaneni KK; Puranam K; Shyamala N; Guditi S; Rapur R; Hanumanth SR
Gene; 2018 Oct; 673():22-31. PubMed ID: 29883760
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR
Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
[TBL] [Abstract][Full Text] [Related]
20. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
Rauramaa R; Väisänen SB; Luong LA; Schmidt-Trücksäss A; Penttilä IM; Bouchard C; Töyry J; Humphries SE
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2657-62. PubMed ID: 11116068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
